STOCK TITAN

[8-K] SIGA Technologies Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Cartesian Growth Corporation II (Nasdaq: RENE/RENEU/RENEW) filed an 8-K disclosing its ninth one-month extension to complete a business combination. The Board moved the deadline, known as the “Business Combination Period,” from 5 Aug 2025 to 5 Sep 2025.

To effect the extension, sponsor CGC II Sponsor LLC will advance $250,000 under an unsecured promissory note that permits borrowings up to $2.4 million. The funds will be deposited into the IPO trust account as required by the company’s amended memorandum and articles.

This is the 9th of 12 permissible monthly extensions; no additional financial results, target identification, or other material transactions were reported.

Cartesian Growth Corporation II (Nasdaq: RENE/RENEU/RENEW) ha depositato un modulo 8-K comunicando la nona proroga di un mese per completare una fusione aziendale. Il Consiglio ha posticipato la scadenza, nota come “Periodo di Combinazione Aziendale,” dal 5 agosto 2025 al 5 settembre 2025.

Per attuare la proroga, lo sponsor CGC II Sponsor LLC anticiperà 250.000 dollari tramite una nota di credito non garantita che consente prestiti fino a 2,4 milioni di dollari. I fondi saranno depositati sul conto fiduciario dell’IPO come previsto dal memorandum e dallo statuto modificati della società.

Questa è la 9ª delle 12 proroghe mensili consentite; non sono stati riportati ulteriori risultati finanziari, identificazione di obiettivi o altre operazioni rilevanti.

Cartesian Growth Corporation II (Nasdaq: RENE/RENEU/RENEW) presentó un formulario 8-K informando sobre su novena prórroga de un mes para completar una combinación de negocios. La Junta movió la fecha límite, conocida como el “Período de Combinación de Negocios,” del 5 de agosto de 2025 al 5 de septiembre de 2025.

Para efectuar la prórroga, el patrocinador CGC II Sponsor LLC adelantará 250,000 dólares bajo un pagaré no garantizado que permite préstamos hasta 2.4 millones de dólares. Los fondos se depositarán en la cuenta fiduciaria de la oferta pública inicial según lo requerido por el memorando y los estatutos enmendados de la compañía.

Esta es la 9ª de 12 prórrogas mensuales permitidas; no se reportaron resultados financieros adicionales, identificación de objetivos ni otras transacciones materiales.

Cartesian Growth Corporation II (나스닥: RENE/RENEU/RENEW)가 8-K 보고서를 제출하며 사업 결합 완료를 위한 아홉 번째 1개월 연장을 공시했습니다. 이사회는 '사업 결합 기간'으로 알려진 마감일을 2025년 8월 5일에서 2025년 9월 5일로 연기했습니다.

연장을 실행하기 위해 스폰서 CGC II Sponsor LLC는 최대 240만 달러까지 차입이 가능한 무담보 약속어음으로 25만 달러를 선지급할 예정입니다. 이 자금은 회사의 수정된 정관 및 각서에 따라 IPO 신탁 계좌에 예치됩니다.

이번이 허용된 12회 중 9번째 월별 연장입니다; 추가 재무 실적, 목표 식별 또는 기타 중요한 거래는 보고되지 않았습니다.

Cartesian Growth Corporation II (Nasdaq : RENE/RENEU/RENEW) a déposé un formulaire 8-K divulguant sa neuvième prolongation d'un mois pour finaliser une fusion d'entreprise. Le conseil d'administration a repoussé la date limite, appelée « Période de fusion d'entreprise », du 5 août 2025 au 5 septembre 2025.

Pour effectuer cette prolongation, le sponsor CGC II Sponsor LLC avancera 250 000 dollars via une reconnaissance de dette non garantie autorisant des emprunts jusqu'à 2,4 millions de dollars. Les fonds seront déposés sur le compte fiduciaire de l'introduction en bourse comme l'exige le mémorandum et les statuts modifiés de la société.

Il s'agit de la 9e des 12 prolongations mensuelles autorisées ; aucun résultat financier supplémentaire, identification de cible ou autre transaction importante n’a été signalé.

Cartesian Growth Corporation II (Nasdaq: RENE/RENEU/RENEW) hat eine 8-K-Meldung eingereicht, in der die neunte einmonatige Verlängerung zur Durchführung einer Unternehmenszusammenführung bekanntgegeben wird. Der Vorstand hat die Frist, bekannt als „Business Combination Period“, vom 5. August 2025 auf den 5. September 2025 verschoben.

Zur Umsetzung der Verlängerung wird der Sponsor CGC II Sponsor LLC 250.000 US-Dollar mittels eines ungesicherten Schuldscheins vorschießen, der Darlehen bis zu 2,4 Millionen US-Dollar erlaubt. Die Mittel werden auf das IPO-Treuhandkonto eingezahlt, wie es die geänderte Satzung des Unternehmens vorsieht.

Dies ist die 9. von 12 zulässigen monatlichen Verlängerungen; keine weiteren finanziellen Ergebnisse, Zielidentifikationen oder sonstige wesentliche Transaktionen wurden gemeldet.

Positive
  • Sponsor advances $250,000 to fund the trust, signaling ongoing financial support.
  • Trust account remains intact, preserving redemption value for public shareholders.
Negative
  • Ninth extension highlights continued inability to secure a merger target, increasing deal uncertainty.
  • Additional borrowing under the $2.4 million note raises leverage ahead of any future transaction.

Insights

TL;DR – Ninth extension keeps SPAC alive but signals difficulty closing a deal; sponsor support limits immediate redemption risk.

Another one-month extension to 5 Sep 2025 indicates CGC II has yet to secure a definitive merger agreement. The sponsor’s $250k deposit demonstrates continued financial backing, protecting the trust value and meeting charter requirements. However, with only three monthly extensions left, time pressure rises and potential targets gain negotiating leverage. Overall impact is neutral: cash safety maintained, but strategic uncertainty persists.

TL;DR – Repeated deadline pushes heighten execution risk; growing sponsor loan increases leverage against future proceeds.

The ninth consecutive extension underscores prolonged deal sourcing challenges, raising the probability of liquidation or shareholder fatigue. Each draw on the unsecured note—now at least $250k—adds liabilities senior to ordinary shareholders upon closing. With only three extensions remaining, investors should monitor note balance growth and any shift in sponsor commitment. From a risk viewpoint, the filing leans negative because timeline slippage and incremental debt can erode eventual transaction economics.

Cartesian Growth Corporation II (Nasdaq: RENE/RENEU/RENEW) ha depositato un modulo 8-K comunicando la nona proroga di un mese per completare una fusione aziendale. Il Consiglio ha posticipato la scadenza, nota come “Periodo di Combinazione Aziendale,” dal 5 agosto 2025 al 5 settembre 2025.

Per attuare la proroga, lo sponsor CGC II Sponsor LLC anticiperà 250.000 dollari tramite una nota di credito non garantita che consente prestiti fino a 2,4 milioni di dollari. I fondi saranno depositati sul conto fiduciario dell’IPO come previsto dal memorandum e dallo statuto modificati della società.

Questa è la 9ª delle 12 proroghe mensili consentite; non sono stati riportati ulteriori risultati finanziari, identificazione di obiettivi o altre operazioni rilevanti.

Cartesian Growth Corporation II (Nasdaq: RENE/RENEU/RENEW) presentó un formulario 8-K informando sobre su novena prórroga de un mes para completar una combinación de negocios. La Junta movió la fecha límite, conocida como el “Período de Combinación de Negocios,” del 5 de agosto de 2025 al 5 de septiembre de 2025.

Para efectuar la prórroga, el patrocinador CGC II Sponsor LLC adelantará 250,000 dólares bajo un pagaré no garantizado que permite préstamos hasta 2.4 millones de dólares. Los fondos se depositarán en la cuenta fiduciaria de la oferta pública inicial según lo requerido por el memorando y los estatutos enmendados de la compañía.

Esta es la 9ª de 12 prórrogas mensuales permitidas; no se reportaron resultados financieros adicionales, identificación de objetivos ni otras transacciones materiales.

Cartesian Growth Corporation II (나스닥: RENE/RENEU/RENEW)가 8-K 보고서를 제출하며 사업 결합 완료를 위한 아홉 번째 1개월 연장을 공시했습니다. 이사회는 '사업 결합 기간'으로 알려진 마감일을 2025년 8월 5일에서 2025년 9월 5일로 연기했습니다.

연장을 실행하기 위해 스폰서 CGC II Sponsor LLC는 최대 240만 달러까지 차입이 가능한 무담보 약속어음으로 25만 달러를 선지급할 예정입니다. 이 자금은 회사의 수정된 정관 및 각서에 따라 IPO 신탁 계좌에 예치됩니다.

이번이 허용된 12회 중 9번째 월별 연장입니다; 추가 재무 실적, 목표 식별 또는 기타 중요한 거래는 보고되지 않았습니다.

Cartesian Growth Corporation II (Nasdaq : RENE/RENEU/RENEW) a déposé un formulaire 8-K divulguant sa neuvième prolongation d'un mois pour finaliser une fusion d'entreprise. Le conseil d'administration a repoussé la date limite, appelée « Période de fusion d'entreprise », du 5 août 2025 au 5 septembre 2025.

Pour effectuer cette prolongation, le sponsor CGC II Sponsor LLC avancera 250 000 dollars via une reconnaissance de dette non garantie autorisant des emprunts jusqu'à 2,4 millions de dollars. Les fonds seront déposés sur le compte fiduciaire de l'introduction en bourse comme l'exige le mémorandum et les statuts modifiés de la société.

Il s'agit de la 9e des 12 prolongations mensuelles autorisées ; aucun résultat financier supplémentaire, identification de cible ou autre transaction importante n’a été signalé.

Cartesian Growth Corporation II (Nasdaq: RENE/RENEU/RENEW) hat eine 8-K-Meldung eingereicht, in der die neunte einmonatige Verlängerung zur Durchführung einer Unternehmenszusammenführung bekanntgegeben wird. Der Vorstand hat die Frist, bekannt als „Business Combination Period“, vom 5. August 2025 auf den 5. September 2025 verschoben.

Zur Umsetzung der Verlängerung wird der Sponsor CGC II Sponsor LLC 250.000 US-Dollar mittels eines ungesicherten Schuldscheins vorschießen, der Darlehen bis zu 2,4 Millionen US-Dollar erlaubt. Die Mittel werden auf das IPO-Treuhandkonto eingezahlt, wie es die geänderte Satzung des Unternehmens vorsieht.

Dies ist die 9. von 12 zulässigen monatlichen Verlängerungen; keine weiteren finanziellen Ergebnisse, Zielidentifikationen oder sonstige wesentliche Transaktionen wurden gemeldet.


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15 (d) OF
THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): August 5, 2025

SIGA TECHNOLOGIES, INC.

(Exact name of registrant as specified in its charter)

Delaware
0-23047
13-3864870
(State or other jurisdiction of incorporation or organization)
(Commission file number)
(I.R.S. employer identification no.)

31 East 62nd Street
New York, New York
 
10065
(Address of principal executive offices)
 
(Zip code)

Registrant’s telephone number, including area code: (212) 672-9100

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class
Trading Symbol(s)
Name of each exchange on which
registered
common stock, $.0001 par value
SIGA
The Nasdaq Global Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



Item 2.02
Results of Operations and Financial Condition.

On August 5, 2025, SIGA Technologies, Inc. (the “Company”) issued a press release (the “Press Release”) announcing its financial results for the quarter ended June 30, 2025.
 
Pursuant to General Instruction B.2 of Form 8-K, the information contained in, or incorporated into, this Item 2.02, including the Press Release, is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”),or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any registration statement or other filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference to such filing.
 
The full text of the Press Release is attached hereto as Exhibit 99.1 and incorporated herein by reference.
 
Item 9.01.
Financial Statements and Exhibits.
 
(d) The following exhibits are included in this report:

Exhibit
No.
 
Description
   
99.1
 
Earning Press Release issued on August 5, 2025.
   
104

Cover Page Interactive Data File (embedded within the Inline XBRL document).


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
SIGA TECHNOLOGIES, INC.
   
 
By:
/s/ Daniel J. Luckshire
 
Name:
Daniel J. Luckshire
 
Title:
Chief Financial Officer
     
Date: August 5, 2025
   



FAQ

Why did RENE/RENEW file this Form 8-K?

The company disclosed approval of its ninth one-month extension to complete a business combination and the related $250,000 sponsor deposit.

What is the new business-combination deadline for Cartesian Growth Corporation II?

The deadline was extended to September 5, 2025.

How much money is being added to the trust account?

$250,000 will be deposited by the sponsor under an unsecured promissory note.

How many extensions remain under the Articles?

Three one-month extensions remain; this was the 9th of 12 allowable extensions.

Does the filing mention any merger target or financial results?

No. The 8-K reports only the extension and related funding; no target or earnings data were provided.
Siga Technologie

NASDAQ:SIGA

SIGA Rankings

SIGA Latest News

SIGA Latest SEC Filings

SIGA Stock Data

461.51M
40.43M
43.34%
51.48%
3.86%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
NEW YORK